Zaidi M, Datta H K, Moonga B S, MacIntyre I
Department of Cellular and Molecular Sciences, St George's Hospital Medical School, London.
J Endocrinol. 1990 Sep;126(3):473-81. doi: 10.1677/joe.0.1260473.
Calcitonin inhibits osteoclastic bone resorption and its action involves two separate acute effects on the osteoclast, both essential to the action of the hormone: abolition of cell motility (Q) and marked cellular retraction (R). The former was mimicked by dibutyryl cyclic AMP and cholera toxin and the latter by pertussis toxin, ionomycin and increases in ambient calcium. Aluminium fluoride ions produced both Q and R effects, while lithium prevented both. In addition, calcitonin elicited a biphasic elevation of cytosolic-free calcium in single isolated osteoclasts. We propose that the action of calcitonin is mediated by at least two G proteins, one responsible for the Q effect and the other for the R effect. In addition, two second messengers, cyclic AMP and calcium, are involved. These findings may help to explain the potency of calcitonin in inhibiting bone resorption, and may allow the rational design of new therapeutic agents designed to alter osteoclast behaviour.
降钙素抑制破骨细胞的骨吸收,其作用涉及对破骨细胞的两种不同的急性效应,这两种效应对于该激素的作用均至关重要:消除细胞运动性(Q)和明显的细胞收缩(R)。前者可被二丁酰环磷腺苷和霍乱毒素模拟,后者可被百日咳毒素、离子霉素以及细胞外钙浓度升高模拟。氟化铝离子可产生Q和R两种效应,而锂则可抑制这两种效应。此外,降钙素可引起单个分离的破骨细胞胞质游离钙的双相升高。我们提出,降钙素的作用至少由两种G蛋白介导,一种负责Q效应,另一种负责R效应。此外,还涉及两种第二信使,即环磷腺苷和钙。这些发现可能有助于解释降钙素抑制骨吸收的效力,并可能有助于合理设计旨在改变破骨细胞行为的新型治疗药物。